Search results
Results from the WOW.Com Content Network
Intraductal papillomas of the breast are benign lesions with an incidence of approximately 2-3% in humans. [1] They result from abnormal proliferation of the epithelial cells lining the breast ducts. [2] Two types of intraductal papillomas are generally distinguished. The central type develops near the nipple.
Papillary carcinomas of the breast (PCB), also termed malignant papillary carcinomas of the breast, are rare forms of the breast cancers. [1] The World Health Organization (2019) classified papillary neoplasms (i.e. benign or cancerous tumors) of the breast into 5 types: intraductal papilloma, papillary ductal carcinoma in situ (PDCIS), encapsulated papillary carcinoma (EPC), solid-papillary ...
Florid cutaneous papillomatosis (FCP) is an obligate paraneoplastic syndrome. FCP begins as the sudden onset of numerous cutaneous papillomas that are clinically indistinguishable from viral warts. The papillomas range from 1 to 3 mm in diameter may spread to involve the entire body, including the face.
With galactography, a larger part of the ductal system can be visualized than with the endoscopic investigation of a duct (called galactoscopy or ductoscopy). Causes for nipple discharge include duct ectasia , intraductal papilloma , and occasionally ductal carcinoma in situ or invasive ductal carcinoma .
The microscopic appearance of a nipple adenoma can be mistaken for carcinoma. [1] Other conditions that have similar symptoms and signs as nipple adenoma include Paget's disease of the breast, other intraductal papillomas, ductal carcinoma in situ (DCIS), syringomatous adenoma of the nipple and subareolar sclerosing duct hyperplasia.
A papilloma (plural papillomas or papillomata) (papillo-+ -oma) is a benign epithelial tumor [1] growing exophytically (outwardly projecting) in nipple-like and often finger-like fronds. In this context, papilla refers to the projection created by the tumor, not a tumor on an already existing papilla (such as the nipple).
(Reuters) -The U.S. health regulator has placed a clinical hold on Iovance Biotherapeutics' trial of its experimental cell therapy in lung cancer patients after a patient death, the company said ...
Benign proliferative breast disease is a group of noncancerous conditions that may increase the risk of developing breast cancer. Examples include atypical ductal hyperplasia, atypical lobular hyperplasia, and intraductal papillomas.